Telugu poet Varavara Rao, who tested COVID positive, moved to Mumbai's Nanavati Hospital for neurological treatment

-

Mumbai: Poet and Elgar Parishad case accused Varavara Rao, a COVID-19 patient, was on Sunday shifted to the Nanavati Hospital in Mumbai for neurological and urological treatment, an official said.

Rao, 80, was undergoing treatment at the state-run St George Hospital in south Mumbai since Thursday after being tested coronavirus positive.

During treatment for COVID-19, doctors found his condition to be stable but also observed he has neurological problems, the official said.

Neurologists from the state-run JJ hospital checked him on Friday and he was diagnosed as having delirium, a hospital official said.

Delirium is an acutely disturbed state of mind characterised by restlessness, illusions, and incoherence, occurring in intoxication, fever, and other disorders.

As he required neurological and urological treatment, he was shifted to the private Nanavati Hospital in the wee hours on Sunday, the official said.

While at St George hospital, Rao responded well to COVID-19 treatment and his chest X-Ray and ECG were normal, he said adding he also underwent a CT Scan.

Rao, an accused in the Elgar Parishad- Maoist links case, was admitted to the JJ Hospital on Monday and was later shifted to St George Hospital, after being tested coronavirus positive.

Lodged in the Taloja jail in neighbouring Navi Mumbai under judicial custody, Rao was admitted to JJ Hospital after his family members and several writers and activists asked Maharashtra government to immediately shift him to hospital for treatment, citing his deteriorating health condition.

Rao's Telangana-based family members had asked jail authorities to provide him immediate medical care, claiming that when he contacted them last week, he was in a "delirious state and hallucinating".

He is behind the bars for about 22 months and had approached the special NIA court, seeking bail on medical grounds and the prevailing COVID-19 situation.

On Monday, he filed two petitions in the Bombay High Court, seeking temporary bail owing to his ill-health and a direction to the jail authorities to produce his medical records and admit him to a state-run or private hospital.

Rao and nine other activists were arrested in the Elgar Parishad-Maoist links case, which was initially probed by the Pune Police and later transferred to the National Investigation Agency (NIA).



from Firstpost India Latest News https://ift.tt/39aY2WI
Press Trust of India

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more